Results 241 to 250 of about 380,196 (292)

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Advances in Ultrasound-Guided Surgery and Artificial Intelligence Applications in Musculoskeletal Diseases. [PDF]

Diagnostics (Basel)
Hattori S, Saggar R, Heidinger E, Qi A, Mullen J, Fee B, Brown CL, Canton SP, Scott D, Hogan MV.   +9 more
europepmc   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source

Editorial: Artificial intelligence in rheumatology and musculoskeletal diseases. [PDF]

Front Med (Lausanne)
Cipolletta E, Fiorentino MC, Vreju FA, Moccia S, Filippucci E.   +4 more
europepmc   +1 more source

Dual Action of Dipyridamole in Experimental Rheumatoid Arthritis: Suppression of Joint Inflammation and Upregulation of Muscle Anabolism via Adenosine and AMPK pathways

Arthritis &Rheumatology, Accepted Article.
Introduction Rheumatoid sarcopenia, characterized by the progressive loss of skeletal muscle mass and function, is a frequent comorbidity in rheumatoid arthritis (RA), linked to prolonged, severe systemic inflammation. Purinergic signaling (adenosine, AMP, and ATP) plays a crucial role in inflammation, myogenesis, and muscle hypertrophy.
Miguel Marco‐Bonilla, Maria Fresnadillo, Irene Sanchez‐Platero, Macarena de la Riva‐Bueno, Fernando Huete‐Toral, Gonzalo Carracedo, Carmen Conde, Yolanda Benitez, Pablo Minguez, Sandra Carolina Cifuentes, Joaquin Rams, Gabriel Herrero‐Beaumont, Raquel Largo, Aránzazu Mediero   +13 more
wiley   +1 more source

Research Trends and Dynamics in Single-cell RNA Sequencing for Musculoskeletal Diseases: A Scientometric and Visualization Study. [PDF]

Int J Med Sci
Cao S, Wei Y, Yue Y, Wang D, Xiong A, Yang J, Zeng H.   +6 more
europepmc   +1 more source

Infrapatellar Fat Pad-Derived Non-Cellular Products in Therapy for Musculoskeletal Diseases: A Scoping Review. [PDF]

Orthop Rev (Pavia)
Triangga AFR, Asmara W, Magetsari R, Bachtiar I, Fazatamma DA, Saraswati PA, Huwaidi AF, Wirohadidjojo YW.   +7 more
europepmc   +1 more source

The Role of Artificial Intelligence in the Primary Prevention of Common Musculoskeletal Diseases. [PDF]

Cureus
Yilmaz Muluk S, Olcucu N.
europepmc   +1 more source

Hands-On Versus Hands-Off Treatment of Hip-Related Nonspecific Musculoskeletal Diseases: A Systematic Review. [PDF]

J Funct Morphol Kinesiol
Franceschi G, Scotto I, Maselli F, Mourad F, Gallotti M.   +4 more
europepmc   +1 more source

Musculoskeletal adaptations to physical interventions in spinal cord injury [PDF]

, 2006
Allen, D., Berry, H., Coupaud, S., Hunt, K., Jamison, L., McLean, A.   +5 more
core